Skip to content

Towards a High-fat Feeding Intervention Study: Identification of Markers for Inflammation and Organ Damage

Towards a High-fat Feeding Intervention Study: Identification of Markers for Inflammation and Organ Damage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00519350
Enrollment
24
Registered
2007-08-22
Start date
2007-08-31
Completion date
2009-06-30
Last updated
2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Systemic Inflammatory Response Syndrome

Keywords

SIRS, sepsis and related syndromes

Brief summary

Patients undergoing major surgery, trauma or burns are prone to develop an exacerbated inflammatory response, which is potentially lethal to the individual. Recently, the researchers' group showed in a rodent model of hemorrhagic shock that high-fat feeding administered before shock attenuates inflammation and reduces intestinal and hepatic damage. In the mechanism that underlies this protective effect, the release of cholecystokinin in gut wall and activation of efferent vagus bundles are crucial events. Before investigating the effect of high-fat nutrition in clinical setting, suitable markers of inflammation and organ damage need to be selected. In this study, blood will be collected in patients undergoing different types of operations. Consequently several markers for inflammation and organ damage will be determined. Hence, suitable parameters for a future high-fat intervention study will be selected.

Interventions

PROCEDUREBlood collection

In arterial or venous lines already present, small amounts of blood will be collected at certain timepoints following operation

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years * elective liver / colon / femur surgery

Exclusion criteria

* Acute inflammation * Chronic Obstructive Respiratory Disease * Recent history of abdominal pain or diarrhea * BMI \< 18.5 * Alcohol or Drugs abuses * Recent intake of antibiotics

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026